The nitric oxide synthases are large, modular, dimeric enzymes composed of a reductase domain, which is related to cytochrome P450 reductase, and a structurally unique oxygenase domain containing a Cys-ligated haem. Both the neuronal and endothelial isoforms are activated by the reversible binding of calmodulin (CaM) at elevated intracellular Ca2+ levels to produce NO as part of a number of cell signalling pathways. CaM binds to the linker region between the two domains and activates the enzyme by inducing intramolecular electron transfer. Protein-engineering experiments have shown that a series of unusual autoinhibitory inserts found only in the CaM-dependent NOS isoforms control both CaM binding and the structural rearrangement it induces. These lie in the reductase domain of the enzyme and include a 40-amino-acid autoinhibitory loop in the FMN-binding module, a 30-amino-acid extension to the C-terminus and the CaM-binding site itself. The substrate (NADPH) also plays an important role in defining the CaM-dependence of the reductase domain by inducing a tight conformational lock in the absence of CaM. Both the substrate and the conformational lock appear to be released on CaM binding; the resultant domain mobility leads to activation.
Skip Nav Destination
Conference Article| June 01 2003
Calmodulin-dependent regulation of mammalian nitric oxide synthase
Biochem Soc Trans (2003) 31 (3): 502–505.
- Views Icon Views
- Share Icon Share
S. Daff; Calmodulin-dependent regulation of mammalian nitric oxide synthase. Biochem Soc Trans 1 June 2003; 31 (3): 502–505. doi: https://doi.org/10.1042/bst0310502
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article